Personalized Smartphone-Enabled Assessment of Blood Pressure and Its Treatment During the SARS-CoV-2 COVID-19 Pandemic in Patients From the CURE-19 Study: Longitudinal Observational Study
The high retention, engagement and acceptability and positive feedback in this study demonstrates that routine monitoring of BP and medications using a smartphone app is feasible for patients with hypertension in a community setting. Remote monitoring of BP and data collection could be coupled with hypertensive medication in a combination product (drug+digital) for precision management of hypertension.
Authors
- Mike Taylor (ORCID: https://orcid.org/0009-0007-4705-5702)
- Thomas Godec (ORCID: https://orcid.org/0000-0001-8119-1352)
- Charles M. Baum (ORCID: https://orcid.org/0000-0003-4481-1211)
- Leanne Richardson (ORCID: https://orcid.org/0000-0002-1233-9613)
- Gregor Timlin (ORCID: https://orcid.org/0009-0000-1635-0062)
- James Siddle (ORCID: https://orcid.org/0000-0003-1080-4603)
- Nihal Noori (ORCID: https://orcid.org/0009-0006-1242-5120)
- Jack Fantham (ORCID: https://orcid.org/0009-0001-5804-5338)
Institutions
- Encore Pharmaceuticals (United States) (US)
- Conservation Leadership Programme (GB)
Publication Details
- Journal
- JMIR mhealth and uhealth
- Published
- 2024-10-07
- DOI
- https://doi.org/10.2196/53430
- Primary Topic
- Blood Pressure and Hypertension Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00